The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure
1 other identifier
observational
30
1 country
1
Brief Summary
The relationship between the activation of the vasopressin system and central hemodynamics in heart failure (including right and left heart filling pressures and cardiac output) is not clear. The investigators intend to examine the correlation between levels of copeptin and vasopressin and the central hemodynamic system in patients with advanced (class III or IV) heart failure. The investigators also aim to examine the relationship of selected cardiac biomarkers in blood and urine with cardiac filling pressures and cardiac output in patients with decompensated heart failure. The study population will consist of 30 patients admitted to the Department of Cardiology at Copenhagen University Hospital. Only patients for whom the attending cardiologist has already decided upon right heart catheterization for clinical/treatment reasons will be recruited for the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 15, 2012
CompletedFirst Posted
Study publicly available on registry
December 12, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedOctober 28, 2015
October 1, 2015
4 years
August 15, 2012
October 26, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
The correlation between levels of plasma copeptin and vasopressin with left ventricular filling pressure and cardiac output
Day 1
Secondary Outcomes (3)
The correlation between levels of plasma copeptin and vasopressin with urine aquaporin-2 concentration
Day 1
The correlation between New York Heart Association (NYHA) class and levels of plasma copeptin and vasopressin
Day 1
The correlation between biomarkers levels and survival free of transplantation- and left ventricular assist device insertion
1 year
Study Arms (1)
Blood and urine samples
Interventions
Eligibility Criteria
The study population will consist of 30 patients with heart failure admitted to the Department of Cardiology at the Copenhagen University Hospital, Rigshospitalet,Dennmark. Only patients who are already referred to right heart catheterization by the attending cardiologist will be recruited for the study.
You may qualify if:
- Age \> 18 years
- Left ventricular ejection fraction \< 40 %
- Diagnosed symptomatic heart failure treated with heart failure medications for at least 30 days.
- Clinical indication for right heart catheterization for clinical/treatment reasons
- NYHA-class III-IV
- Relevant heart failure treatment as tolerated by the patient
You may not qualify if:
- Absence of clinical/treatment indication of right heart catheterization
- Syndrome of Inappropriate Secretion of ADH (SIADH)
- Recent acute myocardial infarction within the last 30 days
- Presence of infection or inflammatory disease
- Malignant disease
- Pregnancy
- Subjects unwilling or unable to provide written consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Finn Gustafssonlead
Study Sites (1)
Department of Cardiology, Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark
Related Publications (1)
Balling L, Goetze JP, Jung MH, Rossing K, Boesgaard S, Gustafsson F. Copeptin levels and invasive hemodynamics in patients with advanced heart failure. Biomark Med. 2018 Aug;12(8):861-870. doi: 10.2217/bmm-2017-0439. Epub 2018 Jul 30.
PMID: 30058349DERIVED
Biospecimen
Blood and urine analyses
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Finn Gustafsson, MD, DMSc
Rigshospitalet, Denmark
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, DMSc
Study Record Dates
First Submitted
August 15, 2012
First Posted
December 12, 2012
Study Start
June 1, 2012
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
October 28, 2015
Record last verified: 2015-10